Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rischin

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Journal of Medical Imaging and Radiation Oncology|November 27, 2008
Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiationJ Corry, W Poon, N McPhee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancerD Rischin, L Peters, R Hicks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neckS J Clarke, J Zalcberg, I Olver, et al.
British Journal of Haematology|April 1, 1996
Association of acquired Pelger-Huet anomaly with taxoid therapyS K Juneja, J P Matthews, R Luzinat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
A phase I trial of docetaxel and gemcitabine in patients with advanced cancerD Rischin, M Boyer, J Smith, et al.
Investigational New Drugs|November 11, 1999
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancerD Rischin, L K Webster, M J Millward, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2005
Parotid-sparing radiotherapy: does it really reduce xerostomia?M K Ng, S V Porceddu, A D Milner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopeniaM A Rosenthal, D Rischin, G McArthur, et al.
British Journal of Cancer|October 14, 2005
A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLCM Michael, A Wirth, D L Ball, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibioticsD Rischin, S P Ackland, J Smith, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Journal of Medical Imaging and Radiation Oncology|November 27, 2008
Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiationJ Corry, W Poon, N McPhee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancerD Rischin, L Peters, R Hicks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neckS J Clarke, J Zalcberg, I Olver, et al.
British Journal of Haematology|April 1, 1996
Association of acquired Pelger-Huet anomaly with taxoid therapyS K Juneja, J P Matthews, R Luzinat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
A phase I trial of docetaxel and gemcitabine in patients with advanced cancerD Rischin, M Boyer, J Smith, et al.
Investigational New Drugs|November 11, 1999
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancerD Rischin, L K Webster, M J Millward, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2005
Parotid-sparing radiotherapy: does it really reduce xerostomia?M K Ng, S V Porceddu, A D Milner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopeniaM A Rosenthal, D Rischin, G McArthur, et al.
British Journal of Cancer|October 14, 2005
A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLCM Michael, A Wirth, D L Ball, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibioticsD Rischin, S P Ackland, J Smith, et al.
Pageof 8